Advertisement
Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal
This is a free web portal for the life sciences in North America, Europe and Israel... » read more
- Limula Raises Oversubscribed CHF6.2m Seed Round (2024-05-21)
> Limula leverages ‘Swiss Made’ engineering and an experienced team to brings much-needed innovation to the field of Cell and Gene Therapy. > Award-winning technology combines a bioreactor and a centrifuge into one single vessel for the first time, opening n... - Scion Instruments Appoints Neil Robertson as CEO (2024-05-21)
We are thrilled to announce that SCION Instruments has a new CEO, Neil Robertson With a proven track record of driving success in his past positions, the new CEO, Neil Robertson, brings a wealth of experience to the table. Previously, Robertson achieved outst... - Accelerated Biosciences and Spanios Partner (2024-05-16)
Spanios, a firm that created and leverages its unique 3D tumoroid platforms to validate solid tumor therapies today announced a partnership with Accelerated Biosciences, a company that licenses its commercial-grade human trophoblast stem cell (hTSC) platform for dr... - Novo Holdings Acquires 60% Stake in Single Use Support (2024-05-15)
The Danish company Novo Holdings has acquired a 60% majority stake in the Austrian-based company Single Use Support, thereby strengthening the company's further growth on a global level. Founded seven years ago by Johannes Kirchmair and Thomas Wurm, Single Use... - NeoSphere Biotechnologies Partners with Kymera Therapeutics (2024-05-14)
NEOsphere Biotechnologies GmbH, a German biotechnology company pioneering high-throughput proteomics to systematically build broad and unique portfolios of novel degrader targets at scale, today announced a collaboration with Kymera Therapeutics, Inc. (NASDAQ: KYMR... - AC Immune & Takeda: up to $2.2b for Alzheimer Drug Candidate (2024-05-13)
- Takeda to receive exclusive option to license global rights to ACI-24.060, a potential first-in-class active immunotherapy designed to delay or slow Alzheimer’s disease progression - AC Immune to receive upfront payment of $100 million upon closing and be el... - Lycia Therapeutics Closes $106.6m Series C Led by Venrock (2024-05-13)
> Venrock Healthcare Capital Partners led the round, with participation from new investors Janus Henderson Investors, Marshall Wace and Franklin Templeton, and continued support from existing investors > Lycia will use proceeds from financing to progress its lea... - Ajax Therapeutics Closes $95m Series C Financing Round (2024-05-13)
– Financing led by Goldman Sachs Alternatives with participation by new investors Lilly, Vivo Capital, RA Capital Management, Point72 and existing investors – – AJ1-11095 will be the first Type II JAK2 Inhibitor to enter the clinic; Phase 1 study in myelo... - ERS Genomics Appoints John E. Milad as CEO (2024-05-13)
ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25 years of experience as an executive leader, venture capitalist, and investment banker focused on the l... - iTeos Announces $120m Registered Direct Offering (2024-05-10)
> Led by existing investors RA Capital Management and Boxer Capital > Purchase price of $17.50 represents a premium of approximately 44% to last close > Further strengthens balance sheet with pro forma cash position of $715 million, extending anticipated runw...
Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!
[LSUS] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the North America, Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!
» Start here with the latest News!Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top